Treating muscle wasting improved cancer survival

May 16, 2018, University of Jyväskylä

Researchers from the University of Jyväskylä in Finland have found that continued treatment of muscle wasting with a soluble growth factor receptor protein, produced at the University of Helsinki, improved survival in a pre-clinical cancer model without affecting the tumour size. This effect was not found when the mice were treated with the recombinant protein only prophylactically before cancer.

"These findings, together with a few earlier rodent studies, as well as a rather large body of epidemiological evidence in humans, have led to suggestions of a possible causal link between the preservation of muscle mass and improved survival. It can be speculated that the preservation of some specific, vital muscles, such as the major respiratory muscles, may be especially important for this ," says Ph.D. student Tuuli Nissinen and the Academy of Finland Research Fellow and group leader Juha Hulmi.

"However," they continue, "our results cannot rule out some muscle-independent effects of our protein. It seems that circulating pro-inflammatory cytokines, physical activity, or hepatic and splenic physiology, which were all altered in , may not be determining factors for improved survival with the soluble growth factor receptor, more specifically soluble activin receptor 2B."

The study was conducted in the Faculty of Sport and Health Sciences at the University of Jyväskylä in collaboration with researchers in Helsinki and Torino. The results are published in the research journal Journal of Cachexia, Sarcopenia and Muscle.

Explore further: Resistance training enhances recycling capacity in muscles

More information: Tuuli A. Nissinen et al, Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses, Journal of Cachexia, Sarcopenia and Muscle (2018). DOI: 10.1002/jcsm.12310

Related Stories

Resistance training enhances recycling capacity in muscles

April 9, 2018
A new study at the University of Jyväskylä, Finland, reports that autophagosome content is increased by resistance training in previously untrained young men, but this response may be blunted by aging. Autophagy is a major ...

Muscle growth finding may assist with cancer treatment

June 13, 2017
Monash University's Biomedicine Discovery Institute (BDI) researchers have collaboratively developed a therapeutic approach that dramatically promotes the growth of muscle mass, which could potentially prevent muscle wasting ...

Menopause and estrogen affect muscle function

October 3, 2017
According to a study conducted at the University of Jyväskylä, estrogen acts as a regulator of muscle energy metabolism and muscle cell viability. Menopause leads to the cessation of ovarian estrogen production concurrent ...

With muscle-building treatment, mice live longer even as tumors grow

August 19, 2010
In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood. Now, researchers reporting in the August 20 issue of Cell, have found some new ...

Uncovering the genetics of skeletal muscle growth and regeneration

March 8, 2018
Skeletal muscle has a remarkable capacity to regenerate - a capacity that is diminished in many skeletal muscle diseases and aging. To investigate the mechanism behind skeletal muscle growth and regeneration, researchers ...

From black hat to white hat: Findings tip assumptions about TAK1 in muscle growth

February 8, 2018
Among researchers exploring the mechanisms of muscle growth and health, there have been certain conceptions about the role of the signaling protein, transforming growth factor-ß-activated kinase 1 (TAK1). Convention was ...

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells

December 11, 2018
A team led by a Massachusetts General Hospital (MGH) investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.